Haemonetics (NYSE:HAE) recently filed with the state of California to confirm a facility closure that affects a total of 75 employees.
According to the California Worker Adjustment and Retraining Notification program, the medtech company notified the state on Oct. 22 and the state processed the filing on Nov. 6. It outlines the permanent closure of a facility in Covina, California, leading to the layoff of 75 employees.
Haemonetics plans for the closure to go into effect on Dec. 31, 2024.
The closure comes as part of plans announced in November 2023 to end the life of its blood inline collection. These products land within the Blood Center business units at Haemonetics. The decision also ended the life of associated manufacturing operations.
Haemonetics also ended the life of the ClotPro system within its Hospital business. The company disclosed the decisions in its Nov. 2 10-Q quarterly report.
A Haemonetics spokesperson shared the following statement to MassDevice via email: